Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of Chlamydia trachomatis , such as cellular envelope polypeptides, which are secreted or specific, or which are involved in metabolism, in the replication process or in virulence, polypeptides encoded by such sequences, as well as vectors including the said sequences and cells or animals transformed with these vectors. The invention also relates to transcriptional gene products of the Chlamydia trachomatis genome, such as, for example, antisense and ribozyme molecules, which can be used to control growth of the microorganism. The invention also relates to methods of detecting these nucleic acids or polypeptides and kits for diagnosing Chlamydia trachomatis infection. The invention also relates to a method of selecting compounds capable of modulating bacterial infection and a method for the biosynthesis or biodegradation of molecules of interest using the said nucleotide sequences or the said polypeptides. The invention finally comprises, pharmaceutical, in particular vaccine, compositions for the prevention and/or treatment of bacterial, in particular Chlamydia trachomatis , infections.
1. An isolated polynucleotide comprising:
a) a polynucleotide encoding ORF 693 (SEQ ID NO: 693) and a heterologous nucleic acid sequence; or
b) polynucleotide that consists of nucleotides 687341 to 688360 of SEQ ID NO: 1.
2. The isolated polynucleotide according to claim 1 , wherein said polynucleotide consists of nucleotides 687341 to 688360 of SEQ ID NO: 1.
3. The isolated polynucleotide according to claim 1 , wherein said polynucleotide comprises nucleotides 687341 to 688360 of SEQ ID NO: 1 and a heterologous nucleic acid sequence.
4. An isolated vector comprising a polynucleotide selected from a polynucleotide encoding ORF 693 (SEQ ID NO: 693).
5. The vector according to claim 4 , wherein said polynucleotide consists of nucleotides 687341 to 688360 of SEQ ID NO: 1.
6. The vector according to claim 4 , wherein said polynucleotide comprises nucleotides 687341 to 688360 of SEQ ID NO: 1.
7. An isolated recombinant host cell comprising a polynucleotide encoding ORF 693 (SEQ ID NO: 693).
8. The recombinant host cell according to claim 7 , wherein said polynucleotide consists of nucleotides 687341 to 688360 of SEQ ID NO: 1.
9. The recombinant host cell according to claim 7 , wherein said polynucleotide comprises nucleotides 687341 to 688360 of SEQ ID NO: 1.
10. A method of making a polypeptide comprising culturing a recombinant host cell comprising a polynucleotide encoding ORF 693 (SEQ ID NO: 693).
11. The method according to claim 10 , wherein said polynucleotide consists of nucleotides 687341 to 688360 of SEQ ID NO: 1.
12. The method according to claim 10 , wherein said polynucleotide comprises nucleotides 687341 to 688360 of SEQ ID NO: 1.